Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Shining a light on metabolic vulnerabilities in non-small cell lung cancer.

Biochimica et biophysica acta. Reviews on cancer - 1 Jan 2021

Dowling Catríona M, Zhang Hua, Chonghaile Tríona Ní, Wong Kwok-Kin

Abstract excerpt

Metabolic reprogramming is a hallmark of cancer which contributes to essential processes required for cell survival, growth, and proliferation. Non-small cell lung cancer (NSCLC) is the most common type of lung cancer and its genomic classification has given rise to the design of therapies targeting tumors harboring specific gene alterations that cause aberrant signaling. Lung tumors are characterized with having...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Non-Small-Cell Lung
Share to Cellular Reprogramming

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Metabolism

Share to Mutation

Share to Signal Transduction

Source

Open in PubMed Open full text

Identifiers

PMID: 33130228
DOI: 10.1016/j.bbcan.2020.188462
PMCID: PMC7836022

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Shining a light on metabolic vulnerabilities in non-small cell lung cancer.PMID 33130228Read ↗

Alternative Energy: Breaking Down the Diverse Metabolic Features of Lung CancersSemantic proximity Read ↗

Therapeutic strategies of metabolic reprogramming in non-small cell lung carcinoma.Semantic proximity Read ↗

Genomic alterations and their correlation with metabolic-related genes in lung cancer.Semantic proximity Read ↗

Oncogene-Driven Metabolic Alterations in CancerSemantic proximity Read ↗

Metabolic Diversity in Human Non-Small Cell Lung Cancer CellsSemantic proximity Read ↗

Reprogramming of Lipid Metabolism in Lung Cancer: An Overview with Focus on EGFR-Mutated Non-Small Cell Lung Cancer.Semantic proximity Read ↗

The hexosamine biosynthesis pathway is a targetable liability in lung cancers with concurrent KRAS and LKB1 mutationsSemantic proximity Read ↗

The hexosamine biosynthesis pathway is a targetable liability in KRAS/LKB1 mutant lung cancer.Semantic proximity Read ↗

Identifying metabolic reprogramming phenotypes with glycolysis-lipid metabolism discoordination and intercellular communication for lung adenocarcinoma metastasis.Semantic proximity Read ↗

Metabolic Reprogramming in Hematologic Malignancies: Advances and Clinical PerspectivesSemantic proximity Read ↗

Comparative metabolomics profiling of isogenic KRAS wild type and mutant NSCLC cells in vitro and in vivo.Semantic proximity Read ↗

The metabolic alterations of cancer cells.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.